Log in
Enquire now

List of Madrigal Pharmaceuticals patents

List of Madrigal Pharmaceuticals patents
List of Superior Energy Services patents
List of MicroGREEN Polymers patents
List of IMTHERA MEDICAL patents
List of babytech companies
List of SBIR/STTR awards granted to Bodkin Design & Engineering, LLC
Patents where
Current Assignee
Name
is
Madrigal PharmaceuticalsMadrigal Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11377447 Targeted therapeutics

Patent 11377447 was granted and assigned to Madrigal Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11377447
July 5, 2022
‌
US Patent 11491145 Combination therapies comprising targeted therapeutics

Patent 11491145 was granted and assigned to Madrigal Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11491145
November 8, 2022
‌
US Patent 9968612 Method of synthesizing thyroid hormone analogs and polymorphs thereof

Patent 9968612 was granted and assigned to Madrigal Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.

‌
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9968612
May 15, 2018
‌
US Patent 9910031 Compositions and methods for modulating c-Rel-dependent cytokine production

Patent 9910031 was granted and assigned to Madrigal Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.

Synta Pharmaceuticals
Synta Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9910031
March 6, 2018
‌
US Patent 11090308 Methods of treating liver disorders or lipid disorders with a THR-beta agonist

Patent 11090308 was granted and assigned to Madrigal Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11090308
August 17, 2021
‌
US Patent 10376598 Targeted therapeutics

Patent 10376598 was granted and assigned to Madrigal Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10376598
August 13, 2019
‌
US Patent 9956293 Targeted therapeutics

Patent 9956293 was granted and assigned to Madrigal Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9956293
May 1, 2018
‌
US Patent 10117944 Targeted therapeutics

Patent 10117944 was granted and assigned to Madrigal Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10117944
November 6, 2018
‌
US Patent 10232049 Targeted therapeutics

Patent 10232049 was granted and assigned to Madrigal Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10232049
March 19, 2019
‌
US Patent 10828315 Targeted therapeutics

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10828315
November 10, 2020
‌
US Patent 10675360 Targeted therapeutics

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10675360
June 9, 2020
‌
US Patent 10722525 Targeted therapeutics

Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10722525
July 28, 2020
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →